Annelies Verbiest onbezoldigd medewerker

Publicaties Annelies Verbiest

Optimal treatment duration in metastatic renal cell carcinoma patients responding to immune checkpoint inhibitors : should we treat beyond two years?

Bron
Acta oncologica - ISSN 0284-186X-64 (2025) p. 979-988
Auteur(s)
    Alexander Decruyenaere, Christine Gennigens, Sylvie Rottey, Annouschka Laenen, Emmanuel Seront, Els Everaert, Philip R. Debruyne, Heidi van den Bulck, Julie Bastin, Annelies Verbiest, Christof Vulsteke, Peter Schatteman, Daisy Luyten, Sandrine Aspeslagh, Nieves Martinez-Chanza, Marlies De Bock, Thomas Meyskens, Jolanda Verheezen, Barbara Brouwers, Benoit Beuselinck